← Leaderboards
Tingting Weng Mills
University Of Texas Hlth Sci Ctr Houston
$2,089,049
Attributed
$3,097,632
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $656.2K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,097,632 · 3
By mechanism
R01$2,777,832 · 2
R56$319,800 · 1
Top collaborators
- Shervin Assassi5 shared
- Zheng Chen1 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Shervin Assassi$2,337,912
- Harry Karmouty-Quintana$5,963,368
- Melissa B Aldrich$2,295,860
- Xiaodong Zhou$2,238,266
- Michael R Blackburn$13,626,157
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingPathogenesisTranscriptUntranslated RegionsLengthGenesIn VitroSitePoly(A) TailPolyadenylationDistalMicrornasRegulationMouse Model3&AposDown-RegulationRepressionEventMortalityProtein ExpressionSamplingPathway InteractionsCellsCytokine
Grant awards (8)
Macrophage NUDT21-mediated alternative polyadenylation in lung injury$531,933
R01 · FY2025 · HL · contact PI
Macrophage NUDT21-mediated alternative polyadenylation in lung injury$548,532
R01 · FY2024 · HL · contact PI
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis$339,816
R01 · FY2023 · AR
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis$336,418
R01 · FY2022 · AR
Regulatory role of APA in pulmonary fibrosis during aging$319,800
R56 · FY2022 · AG · contact PI
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis$329,621
R01 · FY2021 · AR
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis$339,816
R01 · FY2020 · AR
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis$351,696
R01 · FY2019 · AR